Pregnancy after complex myomectomy: neither age of patient nor size, number or location of fibroids should be a barrier. by Talaulikar, VS et al.
 http://shr.sagepub.com/
JRSM Short Reports
 http://shr.sagepub.com/content/3/3/19
The online version of this article can be found at:
 
DOI: 10.1258/shorts.2011.011117
 2012 3: JRSM Short Reports
Vikram Sinai Talaulikar, Sahana Gupta and Isaac Manyonda
should be a barrier
Pregnancy after complex myomectomy: neither age of patient nor size, number or location of fibroids
 
 
Published by:
 http://www.sagepublications.com
On behalf of:
 
 
 The Royal Society of Medicine
 can be found at:JRSM Short ReportsAdditional services and information for 
 
 
 
 
 http://shr.sagepub.com/cgi/alertsEmail Alerts: 
 
 http://shr.sagepub.com/subscriptionsSubscriptions:  
 http://www.sagepub.com/journalsReprints.navReprints: 
 
 http://www.sagepub.com/journalsPermissions.navPermissions: 
 
 What is This?
 
- Mar 1, 2012Version of Record >> 
 at St Georges Library on October 1, 2014shr.sagepub.comDownloaded from 
Pregnancy after complex
myomectomy: neither age of
patient nor size, number or location
of fibroids should be a barrier
Vikram Sinai Talaulikar • Sahana Gupta • Isaac Manyonda
Department of Obstetrics and Gynaecology, St. George’s Hospital, London, UK
Correspondence to: Vikram Sinai Talaulikar. Email: vtalauli@sgul.ac.uk
Within reason the patient’s age and the number,
site or size of fibroids should not be an impedi-
ment to uterus-preserving surgery with a view
to future conception.
Case report 1
This 45-year-old woman was a tertiary referral to
our Myoma Service with a diagnosis of sympto-
matic fibroids confirmed by ultrasound and MRI.
Clinically, the uterine mass was equivalent to
28–30 weeks gestation. In view of her age and
massive fibroids with menorrhagia, she had pre-
viously been offered a hysterectomy but wished
to preserve fertility potential and requested a
myomectomy. Her preoperative haemoglobin
was 11.7 g/dl. After appropriate counseling and
consent, we performed an open myomectomy
(as described below) in June 2009. We removed
55 fibroids weighing 1700 g via two uterine
incisions, one anterior and the other posterior
and both vertical. Some of the fibroids were
huge and highly vascular with blood supply
from large sinuses running over their surfaces.
There were no palpable or visible residual fibroids
at the end of the procedure. The uterine cavity was
not breached and estimated blood loss was
2300 ml. She received two units of blood
transfusion.
Six months after myomectomy she sought egg-
donation IVF in Spain. The uterine cavity assess-
ment was performed by hysteroscopy prior to
beginning of the IVF treatment. It showed pres-
ence of few flimsy synichae within an otherwise
regular uterine cavity. She conceived following
the first treatment cycle. She had an entirely
uncomplicated pregnancy and in June 2011, at 38
weeks gestation and at the age of 47 years, she
underwent a caesarean section delivery of a
healthy female infant weighing 3.47 Kg with
Apgar scores of 9 and 10, and had an uneventful
postoperative recovery.
Case report 2
This 50-year-old public relations manager pre-
sented to our Myoma Service with a recurrence
of fibroids, having had an open myomectomy in
1999 and a transcervical resection of submucous
fibroids (TCRF) in 2001. She had a spontaneous
miscarriage in 2000 and failed IVF following the
TCRF. She was initially diagnosed with a recur-
rence of fibroids in 2003 but took no action as
she was offered hysterectomy while she wished
to preserve fertility potential. Her uterine mass
was equivalent to just over 20 weeks gestation
and was mobile, and ultrasound and MRI con-
firmed fibroids. Her symptoms were predomi-
nantly menorrhagia and sub-fertility. Six months
prior to coming to our service her menses
stopped, and subsequent hormonal profile con-
firmed high levels of FSH suggesting the onset
of menopause. Nevertheless she wished a myo-
mectomy so that she could go ahead with egg-
donation IVF. She had a preoperative haemo-
globin of 12.6 g/dl. Open myomectomy was
performed in August 2009 (details of the pro-
cedure are described below), when 13 fibroids
weighing 985 g were removed. The uterine
cavity was not breached, and blood loss was 600
ml. Six months following surgery she underwent
successful egg-donation IVF in Brazil. The
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uterine cavity assessment by hysteroscopy prior to
embryo transfer showed a fairly normal size and
regular cavity. She had an entirely uncomplicated
pregnancy and in June 2011 she had a caesarean
section delivery of a healthy female infant with
good Apgar scores.
Myomectomy procedure
Both operations were performed via a transverse
suprapubic incision. No preoperative gonadotropin-
releasing hormone (GnRH) analogues were admi-
nistered. Tominimize perioperative blood loss, the
myometrium was infiltrated with vasopressin
(Schofield) 20 units diluted in 100 mL normal
saline and Tranexamic acid 1 gm administered
by slow intravenous infusion at the induction of
anaesthesia. All visible and/or palpable fibroids
were enucleated via two uterine incisions in case
1 and 3; and through incisons in case 2. Vicryl
sutures were used for repair. All women received
thromboprophylaxis and antibiotic prophylaxis.
Discussion
In contemporary practice, women approaching
the end of their reproductive life, presenting
with massive (level of the umbilicus and
beyond) symptomatic fibroids are usually offered
hysterectomy as a definitive cure. If they express
a wish to conserve fertility potential they are
often advised that their prospects are poor.
Uterine artery embolization in such situations
could improve symptoms but may not achieve sig-
nificant uterine involution and is associated with a
risk of precipitating an earlier menopause.1 Its
impact on fertility and pregnancy outcome has
yet to be clearly defined,2 and while it is less inva-
sive and as symptomatically effective and safe as
myomectomy, the latter appears to have superior
reproductive outcomes in the 2 years after treat-
ment.3 For many of these women the finality of a
hysterectomy remains anathema, and women are
becoming increasingly vociferous in what they
wish regarding treatment options. In the modern
era, patient choice and participation in decision-
making is considered good clinical practice. More-
over, women are increasingly putting off
child-bearing to their late thirties and early
forties4, when fibroids are more common and
symptomatic.5 Gynaecologists will therefore
increasingly face demands for uterus-sparing
treatments from such women, and developments
in assisted reproductive technology (ART) render
thewomen’s arguments powerful. The availability
of donor eggs means that it no longer matters that
the quality of their own oocytes may be sub-
optimal, and the in-vitro fertilization (IVF)
approach means that any pelvic adhesions that
may form following extensive myomectomy are
an irrelevance.
We report good outcomes in two women who
presented with massive fibroids requesting
uterus-preserving interventions as they wished
to conceive. Indeed they underwent complex
surgery, one involving the removal of 55 fibroids,
and the other involving a repeat myomectomy.
They were then fortunate to have successful egg-
donation IVF, experiencing entirely uncompli-
cated pregnancies and being delivered of healthy
neonates by elective caesarean section. However,
these cases raise a number of issues open to
debate, including (i) the wisdom or otherwise of
performing surgery that carries considerable mor-
bidity, and indeed mortality where alternative
treatments (hysterectomy) with more definitive
outcomes are available; (ii) the approach to the
surgery itself such as the aim to remove all fibroids
and (iii) the conduct of elective caesarean section
delivery. Since fibroids are common, are asympto-
matic in 50% of women who have them, andmany
women with fibroids have successful reproduc-
tion, it is often debated whether fibroids compro-
mise fertility. However, it is reasonable to
suppose that there must be instances when they
do, such as when they are intra-cavitary,
submucous or distort the uterine cavity, impinge
upon both fallopian tubes and when they are
simply numerous or very large.6 As yet there are
no definitive prospective studies to resolve the
issue, but when a woman presents with sub-
fertility and the only pathology found are fibroids,
then it is logical to remove them. While hyster-
ectomy is usually considered the ‘safer’ operation,
in skilled hands the morbidity and mortality
associated with myomectomy is similar to that
associated with hysterectomy.7 Both myomec-
tomies were performed utilizing transverse supra-
pubic incisions. In our experience it is
exceptionally rare to encounter significant adhe-
sions at primary myomectomy: we therefore
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rarely use a vertical incision, finding that most
fibroids can be removed via a transverse incision.8
In cases with restricted access, an initial debulking
of the lower lying fibroids via the transverse
incision will render the mass deliverable. In both
patients we removed all the fibroids that could be
seen and/or palpated. Should we aim to remove
all the fibroids at myomectomy or does this cause
unnecessary disruption to the uterine anatomy,
increase operating time and increase blood loss?
No one knows the correct answer, but we take the
view that we should remove all fibroids as long
as we do not increase the risk of needing to
proceed to a hysterectomy. We use the minimal
number of incisions on the uterus through which
we enucleate the fibroids – even for a 28 week
size uterus it is not uncommon for us to need just
one anterior and one posterior incision to enucleate
all the fibroids. We believe this minimizes the risk
of pelvic adhesion formation (less raw area for
omental or bowel adhesions to form), and mini-
mally disrupts the uterus. There is evidence to
suggest that vertical anterior incisions are associ-
ated with reduced adhesion formation.9 Although
one could argue whether we should remove ‘only
those fibroids likely to be contributory to the symp-
tomatology’, we do not know how one would
recognize which fibroids are the culprits and how
the remaining are likely to behave in the future
with regard to their growth and their impact on
symptomatology. We not infrequently see women
presenting 2–3 years after a previous myomect-
omy performed elsewhere, usually having been
performed with preopertaive use of GnRH ana-
logues, with so-called ‘recurrence’ of fibroids,
now much larger than at the original presentation,
and of course repeat myomectomy being more
challenging than the primary surgery. Although
we have no rigorous data to back up our view, it
is teleologically sound to suppose that the interval
between primary surgery and true recurrence of
fibroids would be longer if all fibroids were
removed at the primary myomectomy. The use of
GnRH analogues is therefore not only associated
with shrinkage of the smaller fibroids so that they
are missed during surgery only to recur sub-
sequently,10–12 but it also renders the operation
more difficult due to destruction of tissue
planes.13 In addition, it is not possible to predict
how the residual fibroids will behave during sub-
sequent pregnancy. Apparently small fibroids can
enlarge rapidly during pregnancy, and/or
undergo red degeneration causing considerable
pain.14 We therefore advocate avoiding preopera-
tiveGnRHanalogues and the removal of all fibroids
at the primary surgery. We delivered both our
patients by elective caesarean section. Having
removed so many fibroids and therefore having
caused significant scarring to the uterus, we con-
sidered that the scars might not have withstood
the test of labour, and took the soft option.
We also considered the women’s ages, their
history of sub-fertility, and the control and confi-
dence afforded by a planned caesarean section in
broad daylight compared to the scenario of an
emergency caesarean section in the early hours of
the night.
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